Appointment of Director

Global Smaller Cos. Trust PLC (The)
14 November 2023
 

London Stock Exchange Announcement

 

The Global Smaller Companies Trust PLC

 

LEI: 2138008RRULYQP8VP386

Information disclosed in accordance with Listing Rule 9.6.11(1)

 

 

The Board of The Global Smaller Companies Trust PLC is pleased to announce that Bulbul Barrett and Randeep Grewal will be appointed to the Board as independent non-executive Directors with effect from 1 December 2023.

 

 

Bulbul Barrett is Head of Equities Product Group at DBS Bank Ltd London Branch and has over 30 years experience with corporates and investment managers, having formerly been Head of Sales, MD Asian Equities at HSBC, Executive Director, Asian Equities at Goldman Sachs, Director of Asian Equities at UBS and Associate Director, Asian Equities at WI Carr.

 

 

Randeep Grewal is Chairman of Bellevue Healthcare Trust plc and is a non-executive director of Hox Therapeutics Limited. Previously, he was a non-executive director of Tissue Regenix plc. He has extensive experience as a fund manager and analyst, having held the roles of Portfolio Manager at Trium Multi-Strategy Hedge Fund, Senior Portfolio Manager at F&C Asset Management, Analyst at ICAP Equities and Senior Analyst and Portfolio Manager at Tudor Capital. Prior to the above, Randeep was an NHS Doctor, having trained as a vascular surgeon.

 

 

Ms Barrett and Mr Grewal do not own any ordinary shares in the Company.

 

No further information is required to be disclosed under Listing Rule 9.6.13 in respect of this appointment.

 

 

 

14 November 2023

 

 

Enquiries to:

 

Alina Hales

Columbia Threadneedle Investment Business Limited,

Company Secretary

 

T: 020 3530 6250

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings